The MNEmerge research team at the Public Health Foundation of India (PHFI) has analysed the concentration and competition in the pharmaceutical market in India. The study has been published in the multidisciplinary Open Access journal PLOS ONE.
Aashna Mehta, Habib Hasan Farooqui and Sakthivel Selvaraj from PHFI examine in their article the methodological issues with respect to defining the relevant market involved in studying concentration in the pharmaceutical market in India. Furthermore, they have analysed whether the Indian pharmaceutical market is competitive. The researchers argue that the broader market definition correlates with the lower market concentration, and, respectively, as the definition of the market is narrowed down, market concentration increases. Hence, according to the researchers, in order to understand the concentration and competition in the pharmaceutical market, the relevant market should be carefully defined.
Read the complete version of the article: Mehta A, Hasan Farooqui H, Selvaraj S (2016) A Critical Analysis of Concentration and Competition in the Indian Pharmaceutical Market. PLoS ONE 11(2): e0148951. doi:10.1371/journal.pone.0148951.